A Phase 2 Study of Yttrium-90 Ibritumomab Tiuxetan (Zevalin) in Patients With Chronic Lymphocytic Leukemia

BACKGROUND: Radioimmunotherapy (RIT) with radiolabeled monoclonal antibodies to CD20 produce a high response rate in patients with relapsed lymphoma. Use of this modality in patients with chronic lymphocytic leukemia (CLL) has been hampered by the extensive marrow involvement seen in patients with C...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Cancer
Huvudupphovsmän: Jain, Nitin, Wierda, William, Ferrajoli, Alessandra, Wong, Franklin, Lerner, Susan, Keating, Michael, O’Brien, Susan
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2009
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535918/
https://ncbi.nlm.nih.gov/pubmed/19637351
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24522
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk